We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

4.5 CPD hours

Thursday, February 6, 2025
9:20 AM - 10:15 AM
  • Recognising signs and triggers  

  • Treatment options: emollients, topical steroids and immunomodulators   

  • Long-term management and prevention of flares   

 
 
10:25 AM - 11:10 AM
  • The Impact of SABA over reliance
  • Treatment Guidelines including new BTS, NICE, SIGN Nov 24 guidelines
  • Managing Asthma patients: putting evidence into practice
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
Implementing the updated BTS, NICE, SIGN asthma guideline in clinical practice
11:20 AM - 12:05 PM
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
Cardiorenal risk in type 2 diabetes: A case-based discussion
12:15 PM - 1:00 PM
  • The risks of gestational diabetes and the importance of managing glucose   

  • Creating meal plans, modifying schedules and adjusting activity for pregnant patients   

  • Post-partum follow-ups to consider for patients 

 
 
1:10 PM - 1:55 PM
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
COPD patient care: opportunities to improve disease trajectory
2:05 PM - 2:50 PM
  • What is Huntington's disease, a brief overview 

  • Signs and symptoms to be aware of in practice  

  • The role of the nurse in Huntington's disease 

 
 
3:00 PM - 3:45 PM
  • What is bipolar disorder and how can we identify it  

  • Supporting patients through diagnosis 

  • Managing medications and patient support 

 
 
3:45 PM
 
 
 
 

If you are interested in sponsoring a session on the agenda, please contact Ryan Bessent, Event Sales Director